166 related articles for article (PubMed ID: 34165872)
1. Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival.
Azhie A; Sheth P; Hammad A; Woo M; Bhat M
Liver Transpl; 2021 Oct; 27(10):1468-1478. PubMed ID: 34165872
[TBL] [Abstract][Full Text] [Related]
2. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Consequences of Solid Organ Transplantation.
Bhat M; Usmani SE; Azhie A; Woo M
Endocr Rev; 2021 Mar; 42(2):171-197. PubMed ID: 33247713
[TBL] [Abstract][Full Text] [Related]
5. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative Year.
Åberg F; Nordin A; Toivonen L; Isoniemi H
Transplantation; 2016 Feb; 100(2):382-90. PubMed ID: 26683515
[TBL] [Abstract][Full Text] [Related]
6. Sustained Posttransplantation Diabetes Is Associated With Long-Term Major Cardiovascular Events Following Liver Transplantation.
Roccaro GA; Goldberg DS; Hwang WT; Judy R; Thomasson A; Kimmel SE; Forde KA; Lewis JD; Yang YX
Am J Transplant; 2018 Jan; 18(1):207-215. PubMed ID: 28640504
[TBL] [Abstract][Full Text] [Related]
7. The impact of post-transplant diabetes mellitus on liver transplant outcomes.
Lieber SR; Lee RA; Jiang Y; Reuter C; Watkins R; Szempruch K; Gerber DA; Desai CS; DeCherney GS; Barritt AS
Clin Transplant; 2019 Jun; 33(6):e13554. PubMed ID: 30927288
[TBL] [Abstract][Full Text] [Related]
8. Evolving challenges with long-term care of liver transplant recipients.
Odenwald MA; Roth HF; Reticker A; Segovia M; Pillai A
Clin Transplant; 2023 Oct; 37(10):e15085. PubMed ID: 37545440
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes Following Kidney and Liver Transplant in Recipients With HIV.
Zarinsefat A; Gulati A; Shui A; Braun H; Rogers R; Hirose R; Ascher N; Stock P
JAMA Surg; 2022 Mar; 157(3):240-247. PubMed ID: 34985513
[TBL] [Abstract][Full Text] [Related]
10. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
[TBL] [Abstract][Full Text] [Related]
11. Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.
Wang P; Jiang Z; Wang C; Liu X; Li H; Xu D; Zhong L
Front Immunol; 2020; 11():1723. PubMed ID: 33013824
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.
Vandevoorde K; Ducreux S; Bosch A; Guillaud O; Hervieu V; Chambon-Augoyard C; Poinsot D; André P; Scoazec JY; Robinson P; Boillot O; Dubois V; Dumortier J
Liver Transpl; 2018 Aug; 24(8):1091-1100. PubMed ID: 29665189
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review.
Rothbaum Perito E; Lau A; Rhee S; Roberts JP; Rosenthal P
Liver Transpl; 2012 Sep; 18(9):1009-28. PubMed ID: 22641460
[TBL] [Abstract][Full Text] [Related]
14. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.
Malhi H; Allen AM; Watt KD
Curr Opin Organ Transplant; 2016 Apr; 21(2):99-106. PubMed ID: 26825357
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes in pediatric liver transplantation.
Bucuvalas J
Liver Transpl; 2009 Nov; 15 Suppl 2():S6-11. PubMed ID: 19877291
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain.
Legaz I; Navarro-Noguera E; Bolarín JM; García-Alonso AM; Luna Maldonado A; Mrowiec A; Campillo JA; Gimeno L; Moya-Quiles R; Álvarez-López Mdel R; Minguela Puras A; Miras M; Sánchez-Bueno F; Muro M
Alcohol Clin Exp Res; 2016 Apr; 40(4):794-805. PubMed ID: 27012317
[TBL] [Abstract][Full Text] [Related]
19. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection.
Wallia A; Parikh ND; Molitch ME; Mahler E; Tian L; Huang JJ; Levitsky J
Transplantation; 2010 Jan; 89(2):222-6. PubMed ID: 20098286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]